CEO Robert Lisicki takes medical leave; COO Kim Davis appointed interim CEO effective Oct 10

Zura Bio Ltd

CEO Robert Lisicki informed Zura Bio of a medical leave of absence starting October 10, 2025.
Board appointed Kim Davis (COO, CLO, Corporate Secretary) as interim CEO effective October 10, 2025.
Davis will serve as interim CEO in addition to her current duties as COO, CLO, and Corporate Secretary.
No arrangement, transactions under Item 404(a), or family relationships disclosed related to appointment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.